Accessibility Menu
Organigram Global logo

Organigram Global(NASDAQ) OGI

Market Cap$174.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-86%
5 Year-87%
1 Year-18%
1 Month+33%
$1.19
-4.03%
-0.05Today
Organigram Global last closing stock price
MetricPriceDate
Last closeUSD 1.242026-08-19
Organigram Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.88%USD 1.292026-08-12
1 month+33.43%USD 0.932026-07-20
3 month+9.73%USD 1.132026-05-21
Year to date-26.19%USD 1.682025-12-31
1 year-18.42%USD 1.522025-08-19
3 year-21.02%USD 1.572023-08-18
5 year-86.86%USD 9.442021-08-20
Since inception-85.59%USD 8.612014-08-27

Organigram Global Financials at a Glance

Market Cap

$174.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$309.12M

Net Income (TTM)

CA$86.61M

EPS (TTM)

$0.45

P/E Ratio

2.70

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$1.19

Volume

564,924.94

Open

$1.23

Previous Close

$1.24

Daily Range

$1.18 - $1.24

52-Week Range

$0.85 - $2.24

Estimated Earnings Date

Dec 15, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

Organigram Global Inc. is a Canadian company focused on the cultivation, production, and distribution of cannabis and related products. The company serves both the medical and recreational cannabis markets, offering a diverse range of products under well-known brands.

Products and Services
  • Medical cannabis products including flowers and oils
  • Recreational cannabis offerings such as edibles and concentrates
  • Wholesale distribution of cannabis plant cuttings and derivatives
Growth Outlook
  • Recent quarterly revenue reached CAD 105.78 million, a significant increase
  • Strong demand for cannabis products supports future growth potential
  • Expansion into new markets is anticipated to drive revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 263.5 million
  • Net income for the latest quarter was CAD 105.54 million
  • Current ratio of 2.61 indicates strong liquidity position
Organigram Global Inc. has established itself as a key player in the cannabis industry, leveraging its expertise to cater to both medical and recreational consumers. The company's diverse product offerings and strong brand presence position it well for future growth. Recent financial performance highlights a robust revenue increase, reflecting the growing demand for cannabis products. The company's liquidity position, as indicated by a current ratio of 2.61, suggests it is well-equipped to manage its short-term obligations. As the cannabis market continues to evolve, Organigram's strategic initiatives and market expansion efforts are likely to enhance its competitive edge and drive long-term value for stakeholders.
AI Generated • Aug 18, 2026

Industry

Pharmaceuticals

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Headquarters

Toronto, ON M5H 1J8, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-5.67%

Operating Margin

-37.35%

Net Income Margin

28.02%

Return on Equity

21.99%

Return on Capital

-17.72%

Return on Assets

10.56%

Earnings Yield

37.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$174.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

141.01M

Volume

564.92K

Avg. Volume

884.58K

Financials (TTM)

Gross Profit

CA$112.98M

Operating Income

-CA$6.69M

EBITDA

CA$19.08M

Operating Cash Flow

-CA$28.52M

Capital Expenditure

-CA$1.15M

Free Cash Flow

-CA$29.68M

Cash & ST Invst.

CA$11.67M

Total Debt

CA$20.97M

Organigram Global Performance Analysis

Organigram Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 114,623,86583.8%
20232023-09-30CAD 110,622,912-3.5%
20242024-09-30CAD 117,459,8656.2%
20252025-09-30CAD 185,377,62057.8%
Organigram Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-3013.1%
Q12025-12-31-20.7%
Q22026-03-31-5.8%
Q32026-06-3076.9%
Organigram Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -0.15-91.0%
20232023-09-30CAD -2.091339.4%
20242024-09-30CAD -0.35-83.3%
20252025-09-30CAD -0.14-60.4%
Organigram Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-495.7%
Q12025-12-31153.6%
Q22026-03-31-104.7%
Q32026-06-3011100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$105.78M

+49.4%

Gross Profit

CA$41.42M

+58.4%

Gross Margin

39.16%

N/A

Market Cap

$174.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$153.51K

N/A

Employees

1,139

N/A

Net Income

CA$105.54M

+1776.8%

EBITDA

CA$16.13M

+501.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$11.67M

-68.3%

Total Debt

CA$20.97M

+129.3%

Accounts Receivable

CA$88.61M

+54.0%

Inventory

CA$165.06M

+31.8%

Long Term Debt

CA$17.61M

+120.2%

Short Term Debt

CA$3.37M

+192.6%

Return on Assets

10.56%

N/A

Return on Invested Capital

-16.20%

N/A

Free Cash Flow

-CA$3.87M

-177.3%

Operating Cash Flow

-CA$4.30M

-129.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LFCRLifecore Biomedical, Inc.
$4.50+0.90%
DERMJourney Medical Corporation
$7.64+12.16%
ACBAurora Cannabis Inc.
$3.78-3.32%
HSDTSolana Company
$1.89+1.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.82+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.73-0.05%
SPCXSpace Exploration Technologies
$132.34-0.05%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at $1.19 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between $0.85 and $2.24.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$22.17M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$7.65M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.